Given that the hypermethylation of the ANKDD1A promoter occurred predominantly in low grades of glioma, it is possible that the ANKDD1A may also function to be a suppressor in human glioma and inhibit the development of glioma at the early stage. This evidence concerns the gene ANKDD1A and central nervous system cancer.